According to a market report by Lucintel, the future of the global non-invasive coronary imaging market looks promising with opportunities in the hospital, diagnostic imaging center, and research institute markets. The global non-invasive coronary imaging market is expected to reach an estimated $0.25 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are growing prevalence of cardiac diseases, rising need for advanced diagnostic tools, and increasing geriatric population across the globe.
In this market,
radionuclide cardiac imaging, echocardiography, cardiac computed tomography,
and cardiac magnetic resonance imaging are the major segments of non-invasive
coronary imaging market by modality.
Lucintel forecasts that
radionuclide cardiac imaging is expected to witness highest growth over the
forecast period as it ensures non-invasiveness, clarity of image, accurate
detection of disease, reduced isotope doses, and shorter image capture time.
Within this market,
research institute will remain the largest segment due to the growing demand
for the development of precise, non-invasive, and efficient detection
techniques for diagnosing various cardiac disorders, including myocardial
ischemia.
North America will remain
the largest region over the forecast period due to improved healthcare
expenditure by the government, growing number of cancer cases, and increased
research and developmental activities in the region.
Toshiba Medical Systems,
Hologic, Carestream Health, GE Healthcare, Siemens Healthcare, Philips
Healthcare, and Hitachi Medical Corporation are the major suppliers in the
non-invasive coronary imaging market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
No comments:
Post a Comment